Drug Importation: High Risk, Low Reward

Recently, the Department of Health and Human Services (HHS) and the Food and Drug Administration (FDA) unveiled the Safe Importation Action Plan, a proposal to allow drugs to come into the U.S. from abroad with the goal of delivering cost savings for American consumers.

It's tempting to think that legalizing drug importation would immediately give U.S. consumers access to medicines at the prices available in other developed countries. In reality, however, the Safe Importation Action Plan would expose American consumers to significant health risks while achieving meager cost reductions, if any at all.

Read Full Article »
Show comments Hide Comments

Related Articles